<DOC>
	<DOCNO>NCT00507845</DOCNO>
	<brief_summary>Primary : - To assess effectiveness Ramipril-Felodipine hypertensive Argentinean patient Secondary : - To assess tolerability Ramipril-Felodipine hypertensive Argentinean patient .</brief_summary>
	<brief_title>Use Ramipril Felodipine Combination Therapy Hypertension : An Effectiveness Study With Local Patients Argentina</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Ramipril</mesh_term>
	<mesh_term>Felodipine</mesh_term>
	<criteria>Outpatient Patients couldn´t control hypertension 6 week treatment monotherapy ( calcium blocker , beta blocker , diuretic , ACE inhibitor , AT2 blocker ) ( uncontrolled hypertension ) . Already fixeddose combination treatment hypertension Contraindication angiotensin convert enzyme ( ACE ) inhibitor CCB therapy Known hypersensitivity felodipine ( dihydropyridines ) , ramipril , ACE excipients ramipril felodipine . History angioedema Unstable haemodynamic condition : cardiovascular shock , untreated heart failure , acute myocardial infarction , unstable angina pectoris , stroke . Patients AV block II III Severely impair hepatic function . Preexisting bilateral renal artery stenosis stenosis artery solitary kidney Pregnant lactating mother Patients dialysis haemofiltration . Patients creatinine clearance &lt; 20ml/min Use potassium spar diuretic Severe hypertension ( SBP ≥ 180 mmhg DBP ≥ 110 mmhg ) The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2009</verification_date>
</DOC>